AGRO Q1 2026 Post-Earnings Revaluation
May 12, 2026
Stock: $13.50 (post-print) | Q1 EBITDA: $85.8M | Market reaction: +2.8% intraday
Probability-weighted PT: $20.83 | Implied upside: +54%
Recommendation: LONG — thesis intact, outlook reaffirmed by mgmt
Q1 Print: Headline Miss, Substance Beat
| Metric | Actual | My Est | Consensus | Read |
|---|---|---|---|---|
| Revenue ($M) | 398.7 | 372 | 408.9 | In-line |
| Adj EBITDA ($M) | 85.8 | 173 | around 110-120 | Miss |
| EPS ($) | -0.24 | — | +0.25 | -$0.49 |
| Fertilizers EBITDA | 52.5 | 86 | around 45 | Beat vs Street |
| SE&E EBITDA | 40.6 | 45 | around 32 | Strong (+36% YoY) |
| F&A EBITDA | 1.4 | 50 | around 15 | Disaster |
| Net Debt ($M) | 1,630 | 1,500 | — | Higher; 3.2x |
The headline miss is misleading. EPS missed by $0.49 on hyperinflation accounting, FX, and one-offs — but operating EBITDA only missed because F&A collapsed to $1.4M (vs $50M I'd modeled). Critically, management explicitly guided "stronger-than-anticipated Adjusted EBITDA in 2026" and disclosed CFR Brazil urea now at around $725/ton. That's the only number that matters.
The Three Numbers That Reset the Model
Q1 Urea ASP
$517/ton
vs $444 LY (+16%)
Current CFR Brazil
$725/ton
+55% since Feb 28
Q1 Crush
2.2 Mt
Record, +49% YoY
Ethanol Mix
96%
Maximizing margins
Sugar Hedge
65% @ 15.7c
Caps SE&E upside
Q1 Net Debt
$1.63B
3.2x LTM, peak
Revised 2026 EBITDA — Built Up From Q1 Actuals
| Segment | Q1 Actual | Q2-Q4 Est | 2026E Base | Driver |
|---|---|---|---|---|
| Fertilizers | 52.5 | 423 | 476 | Urea $680/ton avg remaining, fixed gas |
| Sugar/Ethanol/Energy | 40.6 | 319 | 360 | LDD crushing growth, 96% ethanol mix |
| Food & Agriculture | 1.4 | 70 | 71 | "Margins improve throughout year" — mgmt |
| Corporate | -8.7 | -23 | -32 | Run rate |
| Total Adj EBITDA | 85.8 | 789 | 875 | +87% on 2025 pro forma |
Scenario Range
| Driver | Bear | Base | Bull |
|---|---|---|---|
| Urea Q2-Q4 avg ($/ton) | 560 | 680 | 800 |
| Profertil EBITDA | 372 | 476 | 580 |
| SE&E EBITDA | 320 | 360 | 400 |
| F&A EBITDA | 30 | 71 | 110 |
| Corporate | -32 | -32 | -32 |
| Total EBITDA ($M) | 690 | 875 | 1,058 |
| Exit EV/EBITDA | 5.0x | 5.5x | 6.0x |
| Price Target | $12.00 | $21.54 | $32.30 |
Probability weighting (30% Bear / 50% Base / 20% Bull): $20.83 per share — implies +54% upside from $13.50.
Where Wall Street Stands
| Source | PT | Implied 2026 EBITDA @ 5.5x | Stance |
|---|---|---|---|
| UBS (Buy) | $16.20 | $1,082M | Bullish, sees Street outdated |
| Citi (Neutral, upgraded Apr 14) | $15.00 | $770M | Cautious on valuation |
| Morgan Stanley | $13.00 | $674M | Equal-weight, under review |
| BofA | $12.20 | $626M | Neutral, lagging |
| BTG Pactual | $17.00 | $830M | Buy |
| Reuters consensus | $13.11 | $555M | Lagging by around 6 weeks |
| Market (current) | $13.50 | $666M | Pricing Bear case |
| My Base case | $21.54 | $875M | Between consensus and UBS |
The dispersion is the opportunity. UBS at $1,082M and Reuters consensus at $555M is a $527M gap — half of the entire LTM EBITDA. Most of the sell-side hasn't updated since the Hormuz spike. Every revision will likely come up, not down. Stock typically tracks consensus revisions with a 1-2 week lag.
Peer Relative Valuation
| Ticker | Business | EV/EBITDA 26E | Note |
|---|---|---|---|
| CF | US nitrogen | 5.5-6.0x | Direct peer, +60% YTD |
| NTR | Global N+P+K | 8.3x | Sold Profertil to AGRO |
| YAR.OL | Europe nitrogen | 6.5x | Gas-disadvantaged |
| SMTO3 | Brazil sugar/ethanol | 5.5x | SE&E peer |
| SLCE3 | Brazil crops | 5.8x | F&A peer |
| AGRO @ current | Blended | 4.2x on Base | Anomalous discount |
| AGRO @ PT $21.54 | Blended | 5.5x | Peer-aligned |
What I Got Wrong (Calibration)
F&A modeling: $50M Q1 est vs $1.4M actual. I underestimated how brutal carry-over stock costs in USD terms would be, and how badly rice/peanut/dairy prices collapsed (4-46% declines). Mgmt cut planted area 22% but the inherited stock still flowed through. Going forward F&A is more like $70M FY than the $130M I had. This is a structural cut to base case.
Sugar hedge cap. 65% of 2026 sugar hedged at 15.7c/lb caps SE&E upside. Even if sugar rallies to 22c+, only 35% of volume benefits. Bull case for SE&E reduced to $400M from $420M.
Got right: Profertil Q1 EBITDA estimate ($86M attributable, actual $52.5M reported but reported number is on Q1 ramp basis pre-Hormuz). Strait of Hormuz catalyst direction. Cash cost of $180-190/ton confirmed by mgmt commentary. UBS's $1,082M estimate validates the methodology.
What Comes Next (Catalysts)
- May 12 conference call (today, 9am NY) — listen for Q2 run-rate urea ASP, gas cost trajectory, F&A margin recovery cadence
- Analyst revisions wave (next 2 weeks) — BofA, Citi, MS still on pre-Hormuz models; expect $2-3 PT raises across the board
- Q2 print (mid-August) — first full quarter at war-time urea pricing; this is THE catalyst. Expect $250-310M EBITDA quarter.
- Hormuz status — every day blockade persists = more bullish Profertil mix
- Second installment dividend (Nov 2026) — capital return signal
Risks
- F&A drag worse than modeled — Q1 was a disaster; if Q2 doesn't show recovery, base case slips $30-50M EBITDA
- Hormuz resolution — quick ceasefire + reopen reverts urea to $440-480, Bear case dominates
- Argentina country risk — peso vol, political risk to RIGI regime (Pampa just filed under it)
- Tether overhang — 74.8% control. If Tether ever liquidates, no bid clears it. Conversely, full-buyout call now seems unlikely given price recovery.
- Leverage at 3.2x LTM — interest cost rising; Moody's B2 limits refi options. Mgmt targets 2.0x medium-term via EBITDA growth.
Options Update
Recommendation from the May 5 analysis still stands but Q1 results validate the timing argument:
- Q1 print did NOT deliver fireworks — stock at $13.50 vs. pre-print $14.24, modest pullback
- IV will compress over the next few days = better entry for new positions
- Primary pick: Sep 18 2026 $17.50 calls @ $1.35 — captures Q2 print (the real catalyst), low IV (62.5%), high OI (1,898)
- Lottery: Sep 18 2026 $20 calls @ $0.65 — best EV/premium ratio, captures upside if analysts chase
- Avoid June expiries (already too short)
- Avoid Dec expiries (theta cheap but no extra catalyst vs Sep)
Bottom Line
Thesis intact, sized higher. The print headline obscures the operational delivery: SE&E hit a Q1 crushing record (+49% volume), Profertil is ramping properly, and management explicitly guided 2026 EBITDA higher than prior expectations. The market knee-jerked on the EPS miss but recovered intraday — that's a constructive tape signal.
My base case 2026 EBITDA comes down from $962M (pre-print) to $875M on F&A weakness, but the urea price flywheel through Q2-Q4 should drive material upside revisions. Probability-weighted PT of $20.83 (vs. prior $24.81) — still +54% upside.
Maintain LONG. Add on weakness below $13. Trim aggressively above $20.
Updated May 12, 2026. Based on actual Q1 2026 results (May 11 print), company outlook commentary, and current CFR Brazil urea pricing of $725/ton. Not financial advice.
No redactions applied.
Published via wiis. Originals are encrypted at rest; this page reflects the redacted version. report abuse.
Discussion
No comments yet.